Fatigue predicts quality of life after leucine-rich glioma-inactivated 1-antibody encephalitis.
Saved in:
| Title: | Fatigue predicts quality of life after leucine-rich glioma-inactivated 1-antibody encephalitis. |
|---|---|
| Authors: | Binks SNM; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, Oxford, UK.; Department of Neurology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Veldsman M; Department of Experimental Psychology, University of Oxford, Oxford, UK., Handel AE; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, Oxford, UK.; Department of Neurology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Jacob S; Department of Neurology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Maddison P; Department of Neurology, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK., Coebergh J; St Peter's Hospital, Ashford and St Peter's NHS Hospitals Foundation Trust, Chertsey, UK., Michael S; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, Oxford, UK.; Department of Neurology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Ramanathan S; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, Oxford, UK.; Translational Neuroimmunology Group, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.; Department of Neurology, Concord Hospital, Sydney, New South Wales, Australia., Easton A; The Encephalitis Society, 32 Castlegate, Malton, North Yorkshire, YO17 7DT, UK.; Department of Clinical Infection, Microbiology and Immunology, University of Liverpool, Liverpool, UK., Nissen MS; Department of Neurology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, DK-5000, Denmark., Leite MI; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, Oxford, UK.; Department of Neurology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Okai D; Neuropsychiatry Department, Maudsley Outpatients, Maudsley Hospital, Denmark Hill, London, SE5 8AZ, UK., Blaabjerg M; Department of Neurology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, DK-5000, Denmark., Husain M; Department of Experimental Psychology, University of Oxford, Oxford, UK.; Nuffield Department of Clinical Neurosciences, Oxford, UK., Irani SR; Oxford Autoimmune Neurology Group, Nuffield Department of Clinical Neurosciences, Oxford, UK.; Department of Neurology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Departments of Neurology and Neurosciences, Mayo Clinic, Jacksonville, Florida, USA. |
| Source: | Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Apr; Vol. 11 (4), pp. 1053-1058. Date of Electronic Publication: 2024 Feb 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Periodicals, Inc on behalf of American Neurological Association Country of Publication: United States NLM ID: 101623278 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2328-9503 (Electronic) Linking ISSN: 23289503 NLM ISO Abbreviation: Ann Clin Transl Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2328-9503 |
|---|---|
| DOI: | 10.1002/acn3.52006 |
